3/24/2021Women's Cancers in China: A Spatio-temporal Epidemiology Analysis

3/24/2021China Declares Early Success in Expanding Online Medical Services

3/24/2021BMS to Offer Steeper Discount for Opdivo in China, Cutting Price to ...

3/24/2021Pharma Research Products Granted Chinse Patent for Hyaluronic Acid Dec...

3/24/2021Hutchmed Sells Non-core OTC Chinese JV with Baiyunshan for $169M

3/24/2021Hainan's Lecheng Pilot Zone Launches Insurance to Cover Innovative New...

3/24/2021Ping An and Zhongshan Hospital Join Hands for Healthcare+Technology+Fi...

3/23/2021Takeda Unveils Open Incubation Platform as Part of Its Digital Strateg...

3/23/2021Regencell Bioscience Files for An $18M US IPO

3/23/2021China Introduces New Program for Early Access to New Drugs in the Grea...

3/23/2021Eucure Announces Breakthu Phase I Results for Anti-CTLA-4 in Combo wit...

3/23/2021Citrine Granted Clinical Trial Waiver for Narcolepsy Drug Wakix and ...

3/23/2021EpimAb Raises $120M Pre-IPO with Global Expansion Aspirations

3/23/2021Everest Med Files NDA for cIAI Drug Xerava (Eravacycline) in China

3/23/2021NMPA Revises Packages Insert of Systemic Quinolone Drugs

3/23/2021NMPA Revises Packages Insert of Mouse Nerve Growth Factor

3/23/2021NIFDC Issues the 2020 National Drug Sample Inspection Annual Report

3/23/2021Review of Chinese CDE-Accepted Drug Registration Applications in 2020

3/22/2021Bayer Launches Prostate Cancer Drugs Nubeqa and Xofigo in China

3/22/2021Sesen and Qilu Announce Chinese IND Approval for Vicineum

3/19/2021Recent Executive Moves

3/18/2021111, Inc. Enters Unique Strategic Partnership with BeiGene

3/18/2021WuXi Biologics to Acquire CMAB and Form Strategic Partnership with CBC...

3/18/2021Complix Agrees with I-Mab to Develop Cell Penetrating Alphabodies aga...

3/18/2021SAMR Issues the Measures on Supervision and Administration of Online T...

3/18/2021NMPA Revises Packages Inserts of Haloperidol Formulations

3/18/2021NMPA Revises Packages Inserts of Sodium Ferulate for Injection

3/18/2021Ping An Good Doctor: Cross-Sectional Survey

3/17/2021Pfizer To Be Granted Priority Review for Its NDA of Abrocitinib

3/17/2021NHSA Releases Its 2020 Healthcare Security Sector Development Statisti...

Page:221/801 Total number of articles:24028: [First][<<] [219] [220] [221] [222] [223] [>>] [End]